EDGAR Filing Documents for 0001564590-16-028928

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-16-028928

Filing Date

2016-11-10

Accepted

2016-11-10 16:17:34

Documents

Period of Report

2016-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	obln-10q_20160930.htm	10-Q	1890237
2	EX-10.6	obln-ex106_175.htm	EX-10.6	91919
3	EX-10.7	obln-ex107_176.htm	EX-10.7	98656
4	EX-31.1	obln-ex311_177.htm	EX-31.1	10580
5	EX-31.2	obln-ex312_178.htm	EX-31.2	10575
6	EX-32.1	obln-ex321_174.htm	EX-32.1	8919
	Complete submission text file	0001564590-16-028928.txt		7651897

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	obln-20160930.xml	EX-101.INS	1717391
8	XBRL TAXONOMY EXTENSION SCHEMA	obln-20160930.xsd	EX-101.SCH	53654
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	obln-20160930_cal.xml	EX-101.CAL	52909
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	obln-20160930_def.xml	EX-101.DEF	194435
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	obln-20160930_lab.xml	EX-101.LAB	401780
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	obln-20160930_pre.xml	EX-101.PRE	326167

Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008

Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400

OBALON THERAPEUTICS INC (Filer) CIK: 0001427570 (see all company filings)